Veoza - direct healthcare professional communication (DHPC)

fezolinetant
DHPCHuman

Bulgarian is available via eTranslation, the European Commission's machine translation service.

Translate to Bulgarian | Important information about machine translation

About

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Документи

Direct healthcare professional communication (DHPC): Veoza (fezolinetant): risk of drug-induced liver injury and new recommendations on monitoring of liver function before and during treatment

English (EN) (212.05 KB - PDF)

Публикувано за първи път:
Виж

Key facts

Medicine name
Veoza
Active substance
fezolinetant
Therapeutic area (MeSH)
  • Menopause
  • Hot Flashes
Procedure number
PSUSA/00000231/202405
Regulatory outcome
Variation
DHPC type
Adverse event
Human ATC codes
G02CX06
Dissemination date

Share this page